Neurocrine Biosciences (NBIX) Tops Q3 EPS by 5c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $140.52 -1.22%
EPS Growth %: -12.4%
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -12.4%
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of $0.64, $0.05 better than the analyst estimate of $0.59. Revenue for the quarter came in at $296 million versus the consensus estimate of $296.65 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- KB Home (KBH) PT Lowered to $50 at RBC Capital
- UBS Reiterates Buy Rating on KB Home (KBH) Amid Transition Back to Built-to-Order
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
